Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Thijs J W van de Laar"'
Autor:
Lianne Koets, Karin van Leeuwen, Maaike Derlagen, Jalenka van Wijk, Nadia Keijzer, Jelena D. M. Feenstra, Manoj Gandhi, Oceane Sorel, Thijs J. W. van de Laar, Marco H. G. M. Koppelman
Publikováno v:
Microbiology Spectrum, Vol 11, Iss 3 (2023)
ABSTRACT Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) variants of concern (VOC) pose an increased risk to public health due to higher transmissibility and/or immune escape. In this study, we assessed the performance of a custom TaqMan
Externí odkaz:
https://doaj.org/article/31c92e31667b4132abe8563b8b18484a
Autor:
Astrid M, Newsum, Amy, Matser, Janke, Schinkel, Marc, van der Valk, Kees, Brinkman, Arne, van Eeden, Fanny N, Lauw, Bart J A, Rijnders, Thijs J W, van de Laar, Marita, van de Kerkhof, Colette, Smit, Anders, Boyd, Joop E, Arends, Maria, Prins, W, van der Veldt
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 73(3), 460-467. Oxford University Press
Clinical infectious diseases, 73(3), 460-467. Oxford University Press
Clinical infectious diseases, 73(3), 460-467. Oxford University Press
Background Human immunodeficiency virus (HIV)-positive men who have sex with men (MSM) are at high risk of hepatitis C virus (HCV) reinfection following clearance of HCV, but risk factors specifically for reinfection have never been comprehensively a
Autor:
Thijs J W van de Laar, Marijke W.A. Molenaar-de Backer, Tanneke Marijt-van der Kreek, Boris M. Hogema, Hans L. Zaaijer
Publikováno v:
Transfusion, 61(7), 2116-2124. Wiley-Blackwell
Background: In the Netherlands, blood donor screening for hepatitis B virus (HBV) consists of HBsAg screening since the 1970s, HBV DNA minipool testing (MP-NAT) since 2008, and anti-HBc screening since 2011. Anti-HBc reactivity causes deferral only i
Autor:
Irene K. Veldhuijzen, Eline L. M. Op de Coul, Milan J. Sonneveld, Adriaan J. van der Meer, Thijs J W van de Laar
Publikováno v:
Journal of Hepatology, 77(3), 896-897. Elsevier
Autor:
Ard van Sighem, Christophe Fraser, Alexandra Blenkinsop, Jeroen van Kampen, Daniela Bezemer, Els Wessels, Oliver Ratmann, Thijs J W van de Laar, Peter Reiss, Marion Cornelissen, Matthew Hall
Publikováno v:
AIDS, 36(1), 83-94. LIPPINCOTT WILLIAMS & WILKINS
AIDS, 36(1), 83-94. Lippincott Williams and Wilkins
AIDS, 36(1), 83-94. Lippincott Williams & Wilkins
AIDS (London, England)
AIDS, 36(1), 83-94. Lippincott Williams and Wilkins
AIDS, 36(1), 83-94. Lippincott Williams & Wilkins
AIDS (London, England)
Objective The aim of this study was to investigate introductions and spread of different HIV-1 subtypes in the Netherlands. Design We identified distinct HIV-1 transmission chains in the Netherlands within the global epidemic context through viral ph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c1677089f4790a0e126ae2536196584
http://hdl.handle.net/1887/3479866
http://hdl.handle.net/1887/3479866
Autor:
Christine Torsvik Steinsvåg, David O. Irving, Pierre Tiberghien, Marjorie Bravo, Josiane Pillonel, Best Collaborative, Mindy Goldman, Ralph R. Vassallo, Marc Germain, Stephen Field, Nelson Hirokazu Tsuno, Katja van den Hurk, Giancarlo M. Liumbruno, Sheila F. O'Brien, Hany Kamel, Minoko Takanashi, Thijs J W van de Laar, Ann Jones, Silvano Wendel, Brian Custer, K. L. Davison, Sarah Morley, Miguel Angel Vesga Carasa, Yves Grégoire
Publikováno v:
Vox Sanguinis, 116(10), 1084-1093. Wiley-Blackwell
for the BEST Collaborative 2021, ' An international comparison of HIV prevalence and incidence in blood donors and general population : a BEST Collaborative study ', Vox Sanguinis, vol. 116, no. 10, pp. 1084-1093 . https://doi.org/10.1111/vox.13107
for the BEST Collaborative 2021, ' An international comparison of HIV prevalence and incidence in blood donors and general population : a BEST Collaborative study ', Vox Sanguinis, vol. 116, no. 10, pp. 1084-1093 . https://doi.org/10.1111/vox.13107
Background and Objectives: Efficiency in mitigating HIV transmission risk by transfusion may vary internationally. We compared HIV prevalence and incidence in blood donors across different jurisdictions in relation to those rates in the general popul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c60ca8b584fda87e6fa4c39575946a4
https://research.vumc.nl/en/publications/80a425e1-ca96-4449-abab-af1429abc7d4
https://research.vumc.nl/en/publications/80a425e1-ca96-4449-abab-af1429abc7d4
Autor:
Hannelore M Götz, Titia Heijman, Birgit H B van Benthem, Eline L. M. Op de Coul, Saara Parkkali, Isabel Slurink, Yolanda van Weert, Karlijn Kampman, Fleur van Aar, Thijs J W van de Laar
Publikováno v:
International Journal of STD & AIDS, 32(10), 946-956
Introduction: Surveillance for recent HIV infections was implemented at Dutch sexual health centres (SHCs) for planning and evaluation of HIV prevention initiatives. The study objective is twofold: (1) to explore trends in recent HIV infections and a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4be0271eb1e5a9d5e997577ee0f47d2b
http://hdl.handle.net/10029/624930
http://hdl.handle.net/10029/624930
Autor:
Isabel A. L. Slurink, Frank van de Baan, Ard I. van Sighem, Alje P. van Dam, Thijs J. W. van de Laar, Godelieve J. de Bree, Birgit H. B. van Benthem, Eline L. M. Op de Coul
Publikováno v:
Frontiers in Reproductive Health, 3(568611):568611
Frontiers in Reproductive Health, 3:568611, 1-9. Frontiers Research Foundation
Frontiers in Reproductive Health, 3:568611, 1-9. Frontiers Research Foundation
Background: Surveillance of recent HIV infections (RHI) using an avidity assay has been implemented at Dutch sexual health centres (SHC) since 2014, but data on RHI diagnosed at other test locations is lacking.Setting: Implementation of the avidity a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5ecfa0dbb530ad1cc7bc4adda11e2ac
https://research.tilburguniversity.edu/en/publications/0ddedfba-85d8-4e09-b8bb-943dcbc2ccc5
https://research.tilburguniversity.edu/en/publications/0ddedfba-85d8-4e09-b8bb-943dcbc2ccc5
Autor:
Colette Smit, Anders Boyd, Bart J A Rijnders, Thijs J W van de Laar, Eliane M Leyten, Wouter F Bierman, Kees Brinkman, Mark A A Claassen, Jan den Hollander, Anne Boerekamps, Astrid M Newsum, Janke Schinkel, Maria Prins, Joop E Arends, Eline L M Op de Coul, Marc van der Valk, Peter Reiss, M. van der Valk, S.E. Geerlings, A. Goorhuis, J.W. Hovius, B. Lempkes, F.J.B. Nellen, T. van der Poll, J.M. Prins, M. van Vugt, W.J. Wiersinga, F.W.M.N. Wit, M. van Duinen, J. van Eden, A. Hazenberg, A.M.H. van Hes, F.J.J. Pijnappel, S.Y. Smalhout, A.M. Weijsenfeld, S. Jurriaans, N.K.T. Back, H.L. Zaaijer, B. Berkhout, M.T.E. Cornelissen, C.J. Schinkel, K.C. Wolthers, E.J.G. Peters, M.A. van Agtmael, R.S. Autar, M. Bomers, K.C.E. Sigaloff, M. Heitmuller, L.M. Laan, C.W. Ang, R. van Houdt, M. Jonges, M. van den Berge, A. Stegeman, S. Baas, L. Hage de Looff, A. Buiting, A. Reuwer, J. Veenemans, B. Wintermans, M.J.H. Pronk, H.S.M. Ammerlaan, D.N.J. van den Bersselaar, E.S. de Munnik, B. Deiman, A.R. Jansz, V. Scharnhorst, J. Tjhie, M.C.A. Wegdam, A. van Eeden, J. Nellen, W. Brokking, L.J.M. Elsenburg, H. Nobel, M.E.E. van Kasteren, M.A.H. Berrevoets, A.E. Brouwer, A. Adams, R. van Erve, B.A.F.M. de Kruijf-van de Wiel, S. Keelan-Phaf, B. van de Ven, A.G.M. Buiting, J.L. Murck, T.E.M.S. de Vries-Sluijs, H.I. Bax, E.C.M. van Gorp, N.C. de Jong-Peltenburg, M. de Mendonça Melo, E. van Nood, J.L. Nouwen, B.J.A. Rijnders, C. Rokx, C.A.M. Schurink, L. Slobbe, A. Verbon, N. Bassant, J.E.A. van Beek, M. Vriesde, L.M. van Zonneveld, J. de Groot, C.A.B. Boucher, M.P.G. Koopmans, J.J.A. van Kampen, J. Branger, R.A. Douma, A.S. Cents-Bosma, C.J.H.M. Duijf-van de Ven, E.F. Schippers, C. van Nieuwkoop, J.M. van IJperen, J. Geilings, N.D. van Burgel, E.M.S. Leyten, G. van der Hut, L.B.S. Gelinck, F. Mollema, S. Davids-Veldhuis, C. Tearno, G.S. Wildenbeest, E. Heikens, P.H.P. Groeneveld, J.W. Bouwhuis, A.J.J. Lammers, S. Kraan, A.G.W. van Hulzen, M.S.M. Kruiper, G.L. van der Bliek, P.C.J. Bor, S.B. Debast, G.H.J. Wagenvoort, F.P. Kroon, M.G.J. de Boer, H. Jolink, M.M.C. Lambregts, A.H.E. Roukens, H. Scheper, W. Dorama, N. van Holten, E.C.J. Claas, E. Wessels, J.G. den Hollander, C.J. Brouwer, J.V. Smit, D. Struik-Kalkman, T. van Niekerk, R. El Moussaoui, K. Pogany, O. Pontesilli, S.H. Lowe, A.M.L. Oude Lashof, D. Posthouwer, M.E. van Wolfswinkel, R.P. Ackens, K. Burgers, J. Schippers, B. Weijenberg-Maes, I.H.M. van Loo, T.R.A. Havenith, M.G.A. van Vonderen, L.M. Kampschreur, S. Faber, R. Steeman-Bouma, A. Al Moujahid, G.J. Kootstra, C.E. Delsing, M. van der Burg-van de Plas, L. Scheiberlich, W. Kortmann, G. van Twillert, R. Renckens, D. Ruiter-Pronk, F.A. van Truijen-Oud, J.W.T. Cohen Stuart, E.R. Jansen, M. Hoogewerf, W. Rozemeijer, W.A. van der Reijden, J.C. Sinnige, K. Brinkman, G.E.L. van den Berk, W.L. Blok, K.D. Lettinga, M. de Regt, W.E.M. Schouten, J.E. Stalenhoef, J. Veenstra, S.M.E. Vrouenraets, H. Blaauw, G.F. Geerders, M.J. Kleene, M. Kok, M. Knapen, I.B. van der Meché, E. Mulder-Seeleman, A.J.M. Toonen, S. Wijnands, E. Wttewaal, D. Kwa, R. van Crevel, A.S.M. Dofferhoff, H.J.M. ter Hofstede, J. Hoogerwerf, M. Keuter, O. Richel, M. Albers, K.J.T. Grintjes-Huisman, M. de Haan, M. Marneef, R. Strik-Albers, J. Rahamat-Langendoen, F.F. Stelma, D. Burger, E.H. Gisolf, R.J. Hassing, M. Claassen, G. ter Beest, P.H.M. van Bentum, N. Langebeek, R. Tiemessen, C.M.A. Swanink, S.F.L. van Lelyveld, R. Soetekouw, L.M.M. van der Prijt, J. van der Swaluw, N. Bermon, R. Jansen, B.L. Herpers, D. Veenendaal, D.W.M. Verhagen, F.N. Lauw, M.C. van Broekhuizen, M. van Wijk, W.F.W. Bierman, M. Bakker, J. Kleinnijenhuis, E. Kloeze, A. Middel, D.F. Postma, Y. Stienstra, M. Wouthuyzen-Bakker, A. Boonstra, H. de Groot-de Jonge, P.A. van der Meulen, D.A. de Weerd, H.G.M. Niesters, C.C. van Leer-Buter, M. Knoester, A.I.M. Hoepelman, J.E. Arends, R.E. Barth, A.H.W. Bruns, P.M. Ellerbroek, T. Mudrikova, J.J. Oosterheert, E.M. Schadd, B.J. van Welzen, K. Aarsman, B.M.G. Griffioen-van Santen, I. de Kroon, M. van Berkel, C.S.A.M. van Rooijen, R. Schuurman, F. Verduyn-Lunel, A.M.J. Wensing, P. Reiss, S. Zaheri, A.C. Boyd, D.O. Bezemer, A.I. van Sighem, C. Smit, M. Hillebregt, A. de Jong, T. Woudstra, D. Bergsma, R. Meijering, L. van de Sande, T. Rutkens, S. van der Vliet, L. de Groot, M. van den Akker, Y. Bakker, A. El Berkaoui, M. Bezemer, N. Brétin, E. Djoechro, M. Groters, E. Kruijne, K.J. Lelivelt, C. Lodewijk, E. Lucas, L. Munjishvili, F. Paling, B. Peeck, C. Ree, R. Regtop, Y. Ruijs, M. Schoorl, P. Schnörr, A. Scheigrond, E. Tuijn, L. Veenenberg, K.M. Visser, E.C. Witte
Publikováno v:
Lancet HIV, 8(2), e96-e105. ELSEVIER SCIENCE INC
ATHENA observational cohort 2021, ' HCV micro-elimination in individuals with HIV in the Netherlands 4 years after universal access to direct-acting antivirals : a retrospective cohort study ', The Lancet HIV, vol. 8, no. 2, pp. e96-e105 . https://doi.org/10.1016/S2352-3018(20)30301-5
Lancet HIV, 8(2), e96-e105. Elsevier Limited
The Lancet HIV, 8, 2, pp. e96-e105
The Lancet HIV, 8(2), e96-e105. Elsevier Limited
The Lancet HIV, 8(2), e96-e105. Elsevier Ltd.
The Lancet HIV, 8, e96-e105
The Lancet HIV, 8(2), E96-E105. ELSEVIER INC
ATHENA observational cohort 2021, ' HCV micro-elimination in individuals with HIV in the Netherlands 4 years after universal access to direct-acting antivirals : a retrospective cohort study ', The Lancet HIV, vol. 8, no. 2, pp. e96-e105 . https://doi.org/10.1016/S2352-3018(20)30301-5
Lancet HIV, 8(2), e96-e105. Elsevier Limited
The Lancet HIV, 8, 2, pp. e96-e105
The Lancet HIV, 8(2), e96-e105. Elsevier Limited
The Lancet HIV, 8(2), e96-e105. Elsevier Ltd.
The Lancet HIV, 8, e96-e105
The Lancet HIV, 8(2), E96-E105. ELSEVIER INC
Contains fulltext : 232443.pdf (Publisher’s version ) (Closed access) BACKGROUND: In the Netherlands, access to direct-acting antivirals (DAAs) against hepatitis C virus (HCV) has been unrestricted for chronic infection since 2015. We evaluated whe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8eae778caf3826362ad6bd5ab3fa741
https://hdl.handle.net/1887/3264392
https://hdl.handle.net/1887/3264392
Autor:
Thijs J W van de Laar, Bert C Baak, Bart van Hoek, Joop E. Arends, Hans Blokzijl, Marc van der Valk, Richard Molenkamp, Cas J. Isfordink, Marjolein Knoester, Els Wessels, Sylvia M Brakenhoff, Cees van Nieuwkoop, Sjoerd Rebers, Janke Schinkel
Publikováno v:
Open Forum Infectious Diseases
Open Forum Infectious Diseases, 8(2). OXFORD UNIV PRESS INC
Open forum infectious diseases, 8(2):ofab006. Oxford University Press
Open Forum Infectious Diseases, 8(2):ofab006. Oxford University Press
Open Forum Infectious Diseases, 8(2). OXFORD UNIV PRESS INC
Open forum infectious diseases, 8(2):ofab006. Oxford University Press
Open Forum Infectious Diseases, 8(2):ofab006. Oxford University Press
Background The majority of hepatitis C virus (HCV) infections are found in low- and middle-income countries, which harbor many region-specific HCV subtypes. Nevertheless, direct-acting antiviral (DAA) trials have almost exclusively been conducted in